Global Information
회사소개 | 문의 | 위시리스트

양전자방출단층촬영(PET) 시스템 : 의료기기 파이프라인 평가

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 05월 상품 코드 358892
페이지 정보 영문 82 Pages
가격
US $ 2,500 ₩ 3,064,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,128,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 9,192,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


양전자방출단층촬영(PET) 시스템 : 의료기기 파이프라인 평가 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 05월 페이지 정보 : 영문 82 Pages

세계 양전자방출단층촬영(이하 PET) 시스템 시장의 주요 파이프라인 제품(의료기기)과 임상시험의 진행 상황에 대해 조사했으며, 제품 기능·특성 비교 분석(임상시험 진행 단계별), 주요 기업 개요 및 대표적 제품, 최근 시장 동향(실적 보고·자본거래 동향 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 양전자 방출 단층촬영(PET) 시스템의 개요

제3장 임상시험중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 지역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 현재 진행중인 임상시험

제4장 임상시험중인 파이프라인 제품 : 기업별

  • PET 시스템 기업 : 임상시험 단계별 파이프라인 제품
  • PET 시스템 : 임상시험 단계별 파이프라인 제품

제5장 PET 시스템 시장 : 기업·제품 개요

  • Brain Biosciences Inc
    • 파이프라인 제품 및 진행중인 임상시험의 개요
  • GE Healthcare Limited
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • The University of British Columbia
  • Zecotek Photonics Inc.

제6장 PET 시스템 시장 : 최근 동향

제7장 부록

도표

KSA 16.06.20

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

1.1 List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: CerePET - Product Status
  • Table 9: CerePET - Product Description
  • Table 10: FREEMotion - Product Status
  • Table 11: FREEMotion - Product Description
  • Table 12: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Q.Clear - Product Status
  • Table 14: Q.Clear - Product Description
  • Table 15: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: CareMiBrain - Product Status
  • Table 17: CareMiBrain - Product Description
  • Table 18: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Positron Emission Tomography System - Product Status
  • Table 20: Positron Emission Tomography System - Product Description
  • Table 21: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: HARLI - Product Status
  • Table 23: HARLI - Product Description
  • Table 24: Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: NVL1 Diagnostic Tracer - Product Status
  • Table 26: NVL1 Diagnostic Tracer - Product Description
  • Table 27: Nuclear, Plasma, and Radiological Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Head And Neck PET System - Product Status
  • Table 29: Head And Neck PET System - Product Description
  • Table 30: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Additional PET Scan - Product Status
  • Table 32: Additional PET Scan - Product Description
  • Table 33: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Helmet - PET System - Product Status
  • Table 35: Helmet - PET System - Product Description
  • Table 36: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Breast-Dedicated PET System - Product Status
  • Table 38: Breast-Dedicated PET System - Product Description
  • Table 39: Dual Panel PET Scanner - Product Status
  • Table 40: Dual Panel PET Scanner - Product Description
  • Table 41: Dual-isotope Positron Emitting Tomography System - Product Status
  • Table 42: Dual-isotope Positron Emitting Tomography System - Product Description
  • Table 43: MR Compatible PET System - Product Status
  • Table 44: MR Compatible PET System - Product Description
  • Table 45: Next Generation TOF-PET System - Product Status
  • Table 46: Next Generation TOF-PET System - Product Description
  • Table 47: PET Sensitivity Enhancing Device - Product Status
  • Table 48: PET Sensitivity Enhancing Device - Product Description
  • Table 49: PET System - Product Status
  • Table 50: PET System - Product Description
  • Table 51: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Arterial PET Scanner - Product Status
  • Table 53: Arterial PET Scanner - Product Description
  • Table 54: Breast PET-MRI - Product Status
  • Table 55: Breast PET-MRI - Product Description
  • Table 56: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: PET Imaging Tool - Product Status
  • Table 58: PET Imaging Tool - Product Description
  • Table 59: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: DS-PS3 Positron Emission Tomography Detector - Product Status
  • Table 61: DS-PS3 Positron Emission Tomography Detector - Product Description
  • Table 62: High Resolution PET Detector - Product Status
  • Table 63: High Resolution PET Detector - Product Description
  • Table 64: PET-Mammogram-Biopsy System - Product Status
  • Table 65: PET-Mammogram-Biopsy System - Product Description
  • Table 66: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Positron Emission Tomography (PET) Imager - Product Status
  • Table 68: Positron Emission Tomography (PET) Imager - Product Description
  • Table 69: Glossary

1.2 List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

  • 2.1 Positron Emission Tomography (PET) Systems Overview

3 Products under Development

  • 3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • 3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • 3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • 3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date

4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies

  • 4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • 4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development

5 Positron Emission Tomography (PET) Systems Companies and Product Overview

  • 5.1 Brain Biosciences Inc Company Overview
  • 5.2 GE Healthcare LLC Company Overview
  • 5.3 General De Equipment for Medical Imaging SA Company Overview
  • 5.4 Jagiellonian University Company Overview
  • 5.5 Lightpoint Medical Ltd Company Overview
  • 5.6 Neurovation Labs Inc Company Overview
  • 5.7 Nuclear, Plasma, and Radiological Engineering Company Overview
  • 5.8 Philips Healthcare Company Overview
  • 5.9 Ray Vision Intl Corp. Company Overview
  • 5.10 Stanford University Company Overview
  • 5.11 SynchroPET Company Overview
  • 5.12 University of British Columbia Company Overview
  • 5.13 University of Washington Company Overview
  • 5.14 West Virginia University Company Overview

6 Positron Emission Tomography (PET) Systems- Recent Developments

  • 6.1 Mar 25, 2019: Inflazome receives funding from The Michael J. Fox Foundation for Parkinson's Research
  • 6.2 Mar 18, 2019: European Association of Urology issues updated guidelines for prostate cancer imaging

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top
전화 문의
F A Q